Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases. [electronic resource]
- Journal of neurochemistry 11 2019
- 397-416 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1471-4159
10.1111/jnc.14635 doi
Alzheimer Disease--diagnosis Biomarkers--metabolism Humans Mass Spectrometry--methods Parkinson Disease--diagnosis Proteomics--methods Sensitivity and Specificity